BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 20232345)

  • 1. Iron in neuronal function and dysfunction.
    Salvador GA
    Biofactors; 2010; 36(2):103-10. PubMed ID: 20232345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.
    Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA
    J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders.
    Sas K; Robotka H; Toldi J; Vécsei L
    J Neurol Sci; 2007 Jun; 257(1-2):221-39. PubMed ID: 17462670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iron, brain ageing and neurodegenerative disorders.
    Zecca L; Youdim MB; Riederer P; Connor JR; Crichton RR
    Nat Rev Neurosci; 2004 Nov; 5(11):863-73. PubMed ID: 15496864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iron and mechanisms of neurotoxicity.
    Salvador GA; Uranga RM; Giusto NM
    Int J Alzheimers Dis; 2010 Dec; 2011():720658. PubMed ID: 21234369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multifunctional activities of green tea catechins in neuroprotection. Modulation of cell survival genes, iron-dependent oxidative stress and PKC signaling pathway.
    Mandel SA; Avramovich-Tirosh Y; Reznichenko L; Zheng H; Weinreb O; Amit T; Youdim MB
    Neurosignals; 2005; 14(1-2):46-60. PubMed ID: 15956814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitric oxide and cellular stress response in brain aging and neurodegenerative disorders: the role of vitagenes.
    Calabrese V; Boyd-Kimball D; Scapagnini G; Butterfield DA
    In Vivo; 2004; 18(3):245-67. PubMed ID: 15341181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iron: a new target for pharmacological intervention in neurodegenerative diseases.
    Whitnall M; Richardson DR
    Semin Pediatr Neurol; 2006 Sep; 13(3):186-97. PubMed ID: 17101458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Intracellular signaling pathways, apoptosis and neurodegenerative diseases].
    Marcilhac A
    Psychol Neuropsychiatr Vieil; 2004 Sep; 2(3):203-14. PubMed ID: 15689335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bifunctional drug derivatives of MAO-B inhibitor rasagiline and iron chelator VK-28 as a more effective approach to treatment of brain ageing and ageing neurodegenerative diseases.
    Youdim MB; Fridkin M; Zheng H
    Mech Ageing Dev; 2005 Feb; 126(2):317-26. PubMed ID: 15621213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Oxidative stress in neurodegeneration].
    González-Fraguela ME; Castellano-Benítez O; González-Hoyuela M
    Rev Neurol; 1999 Mar 1-15; 28(5):504-11. PubMed ID: 10229967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The transition metals copper and iron in neurodegenerative diseases.
    Rivera-Mancía S; Pérez-Neri I; Ríos C; Tristán-López L; Rivera-Espinosa L; Montes S
    Chem Biol Interact; 2010 Jul; 186(2):184-99. PubMed ID: 20399203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relevance of iron in the pathogenesis of Parkinson's disease.
    Sian-Hülsmann J; Mandel S; Youdim MB; Riederer P
    J Neurochem; 2011 Sep; 118(6):939-57. PubMed ID: 21138437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does cellular iron dysregulation play a causative role in Parkinson's disease?
    Kaur D; Andersen J
    Ageing Res Rev; 2004 Jul; 3(3):327-43. PubMed ID: 15231240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iron toxicity in neurodegeneration.
    Núñez MT; Urrutia P; Mena N; Aguirre P; Tapia V; Salazar J
    Biometals; 2012 Aug; 25(4):761-76. PubMed ID: 22318507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iron involvement in neural damage and microgliosis in models of neurodegenerative diseases.
    Shoham S; Youdim MB
    Cell Mol Biol (Noisy-le-grand); 2000 Jun; 46(4):743-60. PubMed ID: 10875437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Iron as a vulnerability factor in nigrostriatal degeneration in aging and Parkinson's disease.
    Floor E
    Cell Mol Biol (Noisy-le-grand); 2000 Jun; 46(4):709-20. PubMed ID: 10875434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Submolecular adventures of brain tyrosine: what are we searching for now?
    Kochman A; Kośka C; Metodiewa D
    Amino Acids; 2002; 23(1-3):95-101. PubMed ID: 12373523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reelin-mediated signaling in neuropsychiatric and neurodegenerative diseases.
    Knuesel I
    Prog Neurobiol; 2010 Aug; 91(4):257-74. PubMed ID: 20417248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular pathways leading to neuronal dysfunction and degeneration.
    Kazantsev AG
    Drug News Perspect; 2007 Oct; 20(8):501-9. PubMed ID: 18080037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.